The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer

Elisabeth Brenne (Corresponding Author), Jon H Loge, Hanne Lie, Marianne J Hjermstad, Peter Fayers, Stein Kaasa

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background:
Depressive symptoms are prevalent in patients with advanced cancer, sometimes of a severity that fulfil the criteria for a major depressive episode.

Aim:
The aim of this study was to investigate how the item on depression in the Edmonton Symptom Assessment System with a 0–10 Numerical Rating Scale performed as a screener for major depressive episode. A possible improved performance by adding the Edmonton Symptom Assessment System-Anxiety item was also examined.

Design:
An international cross-sectional study including patients with incurable cancer was conducted. The Edmonton Symptom Assessment System score was compared against major depressive episode as assessed by the Patient Health Questionnaire-9. Screening performance was examined by sensitivity, specificity and the kappa coefficient.

Setting:
Patients with incurable cancer (n = 969), median age 63 years and from eight nationalities provided report. Median Karnofsky Performance Status was 70. Median survival was 229 days (205–255 days).

Results:
Patient Health Questionnaire-9 major depressive episode was present in 133 of 969 patients (13.7%). Edmonton Symptom Assessment System-Depression screening ability for Patient Health Questionnaire-9 major depressive episode was limited. Area under the receiver operating characteristic curve was 0.71 (0.66–0.76). Valid detection or exclusion of Patient Health Questionnaire-9 major depressive episode could not be concluded at any Edmonton Symptom Assessment System-Depression cut-off; by the cut-off Numerical Rating Scale ⩾ 2, sensitivity was 0.69 and specificity was 0.60. By the cut-off Numerical Rating Scale ⩾ 4, sensitivity was 0.51 and specificity was 0.82. Combined mean ratings by Edmonton Symptom Assessment System-Depression and Edmonton Symptom Assessment System-Anxiety revealed similar limited screening ability.

Conclusion:
The depression and anxiety items of the Edmonton Symptom Assessment System, a frequently used assessment tool in palliative care settings, seem to measure a construct other than major depressive episode as assessed by the Patient Health Questionnaire-9 instrument.
Original languageEnglish
Pages (from-to)587-598
Number of pages12
JournalPalliative Medicine
Volume30
Issue number6
Early online date13 Jan 2016
DOIs
Publication statusPublished - 30 Jun 2016

Fingerprint

Symptom Assessment
Depression
Neoplasms
Health
Aptitude
Anxiety
Karnofsky Performance Status
Palliative Care
Ethnic Groups
ROC Curve
Cross-Sectional Studies
Surveys and Questionnaires
Sensitivity and Specificity
Survival

Keywords

  • Palliative care
  • Neoplasms
  • depression
  • Depressive disorder
  • symptom assessment

Cite this

The Edmonton Symptom Assessment System : Poor performance as screener for major depression in patients with incurable cancer. / Brenne, Elisabeth (Corresponding Author); Loge, Jon H; Lie, Hanne; Hjermstad, Marianne J; Fayers, Peter; Kaasa, Stein.

In: Palliative Medicine, Vol. 30, No. 6, 30.06.2016, p. 587-598.

Research output: Contribution to journalArticle

Brenne, Elisabeth ; Loge, Jon H ; Lie, Hanne ; Hjermstad, Marianne J ; Fayers, Peter ; Kaasa, Stein. / The Edmonton Symptom Assessment System : Poor performance as screener for major depression in patients with incurable cancer. In: Palliative Medicine. 2016 ; Vol. 30, No. 6. pp. 587-598.
@article{7e0c57298c9f4beb8aba44a8c0f6df04,
title = "The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer",
abstract = "Background:Depressive symptoms are prevalent in patients with advanced cancer, sometimes of a severity that fulfil the criteria for a major depressive episode.Aim:The aim of this study was to investigate how the item on depression in the Edmonton Symptom Assessment System with a 0–10 Numerical Rating Scale performed as a screener for major depressive episode. A possible improved performance by adding the Edmonton Symptom Assessment System-Anxiety item was also examined.Design:An international cross-sectional study including patients with incurable cancer was conducted. The Edmonton Symptom Assessment System score was compared against major depressive episode as assessed by the Patient Health Questionnaire-9. Screening performance was examined by sensitivity, specificity and the kappa coefficient.Setting:Patients with incurable cancer (n = 969), median age 63 years and from eight nationalities provided report. Median Karnofsky Performance Status was 70. Median survival was 229 days (205–255 days).Results:Patient Health Questionnaire-9 major depressive episode was present in 133 of 969 patients (13.7{\%}). Edmonton Symptom Assessment System-Depression screening ability for Patient Health Questionnaire-9 major depressive episode was limited. Area under the receiver operating characteristic curve was 0.71 (0.66–0.76). Valid detection or exclusion of Patient Health Questionnaire-9 major depressive episode could not be concluded at any Edmonton Symptom Assessment System-Depression cut-off; by the cut-off Numerical Rating Scale ⩾ 2, sensitivity was 0.69 and specificity was 0.60. By the cut-off Numerical Rating Scale ⩾ 4, sensitivity was 0.51 and specificity was 0.82. Combined mean ratings by Edmonton Symptom Assessment System-Depression and Edmonton Symptom Assessment System-Anxiety revealed similar limited screening ability.Conclusion:The depression and anxiety items of the Edmonton Symptom Assessment System, a frequently used assessment tool in palliative care settings, seem to measure a construct other than major depressive episode as assessed by the Patient Health Questionnaire-9 instrument.",
keywords = "Palliative care, Neoplasms, depression, Depressive disorder, symptom assessment",
author = "Elisabeth Brenne and Loge, {Jon H} and Hanne Lie and Hjermstad, {Marianne J} and Peter Fayers and Stein Kaasa",
note = "Funding This study was supported by the European Commission’s Sixth Framework Programme (contract no LSHC-CT-2006-037777), PI Stein Kaasa, with the overall aim to improve treatment of pain, depression and fatigue through translation research and funding from Trondheim University Hospital, Norway. Elisabeth Brenne received a grant from the Norwegian Cancer Society.",
year = "2016",
month = "6",
day = "30",
doi = "10.1177/0269216315620082",
language = "English",
volume = "30",
pages = "587--598",
journal = "Palliative Medicine",
issn = "0269-2163",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - The Edmonton Symptom Assessment System

T2 - Poor performance as screener for major depression in patients with incurable cancer

AU - Brenne, Elisabeth

AU - Loge, Jon H

AU - Lie, Hanne

AU - Hjermstad, Marianne J

AU - Fayers, Peter

AU - Kaasa, Stein

N1 - Funding This study was supported by the European Commission’s Sixth Framework Programme (contract no LSHC-CT-2006-037777), PI Stein Kaasa, with the overall aim to improve treatment of pain, depression and fatigue through translation research and funding from Trondheim University Hospital, Norway. Elisabeth Brenne received a grant from the Norwegian Cancer Society.

PY - 2016/6/30

Y1 - 2016/6/30

N2 - Background:Depressive symptoms are prevalent in patients with advanced cancer, sometimes of a severity that fulfil the criteria for a major depressive episode.Aim:The aim of this study was to investigate how the item on depression in the Edmonton Symptom Assessment System with a 0–10 Numerical Rating Scale performed as a screener for major depressive episode. A possible improved performance by adding the Edmonton Symptom Assessment System-Anxiety item was also examined.Design:An international cross-sectional study including patients with incurable cancer was conducted. The Edmonton Symptom Assessment System score was compared against major depressive episode as assessed by the Patient Health Questionnaire-9. Screening performance was examined by sensitivity, specificity and the kappa coefficient.Setting:Patients with incurable cancer (n = 969), median age 63 years and from eight nationalities provided report. Median Karnofsky Performance Status was 70. Median survival was 229 days (205–255 days).Results:Patient Health Questionnaire-9 major depressive episode was present in 133 of 969 patients (13.7%). Edmonton Symptom Assessment System-Depression screening ability for Patient Health Questionnaire-9 major depressive episode was limited. Area under the receiver operating characteristic curve was 0.71 (0.66–0.76). Valid detection or exclusion of Patient Health Questionnaire-9 major depressive episode could not be concluded at any Edmonton Symptom Assessment System-Depression cut-off; by the cut-off Numerical Rating Scale ⩾ 2, sensitivity was 0.69 and specificity was 0.60. By the cut-off Numerical Rating Scale ⩾ 4, sensitivity was 0.51 and specificity was 0.82. Combined mean ratings by Edmonton Symptom Assessment System-Depression and Edmonton Symptom Assessment System-Anxiety revealed similar limited screening ability.Conclusion:The depression and anxiety items of the Edmonton Symptom Assessment System, a frequently used assessment tool in palliative care settings, seem to measure a construct other than major depressive episode as assessed by the Patient Health Questionnaire-9 instrument.

AB - Background:Depressive symptoms are prevalent in patients with advanced cancer, sometimes of a severity that fulfil the criteria for a major depressive episode.Aim:The aim of this study was to investigate how the item on depression in the Edmonton Symptom Assessment System with a 0–10 Numerical Rating Scale performed as a screener for major depressive episode. A possible improved performance by adding the Edmonton Symptom Assessment System-Anxiety item was also examined.Design:An international cross-sectional study including patients with incurable cancer was conducted. The Edmonton Symptom Assessment System score was compared against major depressive episode as assessed by the Patient Health Questionnaire-9. Screening performance was examined by sensitivity, specificity and the kappa coefficient.Setting:Patients with incurable cancer (n = 969), median age 63 years and from eight nationalities provided report. Median Karnofsky Performance Status was 70. Median survival was 229 days (205–255 days).Results:Patient Health Questionnaire-9 major depressive episode was present in 133 of 969 patients (13.7%). Edmonton Symptom Assessment System-Depression screening ability for Patient Health Questionnaire-9 major depressive episode was limited. Area under the receiver operating characteristic curve was 0.71 (0.66–0.76). Valid detection or exclusion of Patient Health Questionnaire-9 major depressive episode could not be concluded at any Edmonton Symptom Assessment System-Depression cut-off; by the cut-off Numerical Rating Scale ⩾ 2, sensitivity was 0.69 and specificity was 0.60. By the cut-off Numerical Rating Scale ⩾ 4, sensitivity was 0.51 and specificity was 0.82. Combined mean ratings by Edmonton Symptom Assessment System-Depression and Edmonton Symptom Assessment System-Anxiety revealed similar limited screening ability.Conclusion:The depression and anxiety items of the Edmonton Symptom Assessment System, a frequently used assessment tool in palliative care settings, seem to measure a construct other than major depressive episode as assessed by the Patient Health Questionnaire-9 instrument.

KW - Palliative care

KW - Neoplasms

KW - depression

KW - Depressive disorder

KW - symptom assessment

U2 - 10.1177/0269216315620082

DO - 10.1177/0269216315620082

M3 - Article

VL - 30

SP - 587

EP - 598

JO - Palliative Medicine

JF - Palliative Medicine

SN - 0269-2163

IS - 6

ER -